retatrutide type 2 diabetes phase 2 results 2024 2025 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Perceived benefits of treatment for

Exenatide as a potential treatment for patients with Parkinsons disease: first steps into the clinic

One particular study conducted by Harvard showed that after just once a week of administering NAD therapy, the tissue from the mice resembled those of mice a quarter of their age

The primary phenolic compound found in olive oil, known as hydroxytyrosol, has been observed to reduce platelet aggregation in humans (234) significantly

10.1016/j.bbrc.2019.11.137 48 GehrP

Tirzepatide is $289 monthly month-to-month through PlexusDx, compared to semaglutide at $189 monthly

This article covers exactly how receptor downregulation occurs with daily dosing, what cycle structures preserve sensitivity, and what dosing mistakes render the peptide ineffective halfway through a protocol